ABBV Jun 2023 115.000 call
| Previous close | 30.75 |
| Open | 30.95 |
| Bid | 32.15 |
| Ask | 32.55 |
| Strike | 115.00 |
| Expiry date | 2023-06-16 |
| Day's range | 30.75 - 30.95 |
| Contract range | N/A |
| Volume | |
| Open interest | 376 |
- Motley Fool
If You Want Tons of Passive Income in the Future , Buy These 2 Stocks
Building a stream of dividends to fatten your wallet every quarter is a lot easier when you're willing to play the long game. AbbVie (NYSE: ABBV) is a passive-income machine, and this is all thanks to its ability to churn out therapies at an industrial scale. Strong earnings growth is likely to continue in the long run -- after a short delay, that is.
- Zacks
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- Motley Fool
2 Steady Stocks to Buy in a Recession
Buying shares of such companies can help investors strengthen their portfolios and make them recession proof, so to speak. Let's look at two stocks to buy if a recession hits this year: AbbVie (NYSE: ABBV) and Incyte (NASDAQ: INCY). AbbVie is one of the largest pharmaceutical companies in the world.
